Clinical Trials Logo

Ebola Vaccine clinical trials

View clinical trials related to Ebola Vaccine.

Filter by:
  • None
  • Page 1

NCT ID: NCT05959421 Not yet recruiting - Ebola Vaccine Clinical Trials

Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure

PREPARE
Start date: September 2024
Phase: Phase 3
Study type: Interventional

This study is a multi-center, open label, randomized phase 3b trial to assess the durability of Immunity induced by the Ebolavirus Vaccine VSV-EBOV ( with or without booster vaccination) in individuals at potential occupational risk for ebolavirus exposure

NCT ID: NCT02464670 Completed - Ebola Vaccine Clinical Trials

Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers

Start date: May 2015
Phase: Phase 1
Study type: Interventional

This study evaluates whether INO-4212 and its components INO-4201 and INO-4202 administered intramuscularly (IM) or intradermally (ID) followed by electroporation (EP) will be well tolerated and immunogenic.